These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11377035)

  • 1. Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS.
    Feng W; Liu H; Chen G; Malchow R; Bennett F; Lin E; Pramanik B; Chan TM
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):545-57. PubMed ID: 11377035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
    Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
    J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
    Narayanam M; Sahu A; Singh S
    J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of a novel degradant of the antifungal agent posaconazole.
    Zhong W; Yang X; Tong W; Martin GE
    J Pharm Biomed Anal; 2012 Jul; 66():40-9. PubMed ID: 22464557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
    Bu HZ; Poglod M; Micetich RG; Khan JK
    J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of neem oils by LC-MS and degradation kinetics of azadirachtin-A in a controlled environment. Characterization of degradation products by HPLC-MS-MS.
    Barrek S; Paisse O; Grenier-Loustalot MF
    Anal Bioanal Chem; 2004 Feb; 378(3):753-63. PubMed ID: 14685815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.
    Baira SM; R S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Feb; 165():399-409. PubMed ID: 30590338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on structural characterization of degradation products of cangrelor using LC/QTOF/MS/MS and NMR.
    Guvvala V; Chidambaram Subramanian V; Anireddy JS
    J Pharm Biomed Anal; 2019 Jun; 170():327-334. PubMed ID: 30978606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of major degradation products of an adenosine A2A receptor antagonist under stressed conditions by LC-MS and FT tandem MS analysis.
    Zhang LK; Pramanik BN
    J Mass Spectrom; 2010 Feb; 45(2):146-56. PubMed ID: 19911413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
    Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
    J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of LC-NMR and LC-MS to the identification of degradation products of a protease inhibitor in dosage formulations.
    Peng SX; Borah B; Dobson RL; Liu YD; Pikul S
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):75-89. PubMed ID: 10704011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR.
    Djabrouhou N; Guermouche MH
    J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of pseudo degradation products of acalabrutinib using ESI-HRMS/MS and NMR: Formation of possible geometrical isomers.
    Panda S; Das M; Kandula RR; Gajjela R; Ravuri NDH; Kumar H; Kalamse S; Mathur A; Roy A; Bagadi M
    J Pharm Biomed Anal; 2023 Feb; 225():115214. PubMed ID: 36621281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.